|

Targeted CEA CAR-T Clinical Trials

4 actively recruiting trials

Pipeline

Phase 1: 4

Top Sponsors

  • Chongqing Precision Biotech Co., Ltd4

Indications

  • Advanced Lung Cancer4
  • Lung Cancer4
  • Cancer4

Other4 trials

A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Phase 1
Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma
Phase 1
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
Phase 1
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.